Our Underwriters

Print this page         

The survey on Patient Experience with Clinical Trial Materials has been made possible by the generous support of eleven underwriting companies. Their investment in the mission and work of ISPE has allowed the Patient Initiative task force to design and carry out this comprehensive project to the ultimate benefit patients around the world. ISPE wishes to thank the underwriters including:

  • Almac
  • Boehringer Ingelheim Pharma GMBH & Co.
  • Catalent Pharma Solutions
  • Cenduit LLC
  • Merck Sharp & Dohme Corporation
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • PAREXEL International
  • Pfizer Inc.
  • Takeda Development Centre Europe Ltd
  • UCB Pharma S.A.


Underwriter Logos

My ISPE

  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile

ISPEAK Logo

An ISPE
Information
Resource

Innovation Forum – Connecting with Thought Leaders
Wednesday, 27 Jul 2016 14.07

Reimagining Medicine – The Novartis Mission
Tuesday, 26 Jul 2016 13.07

GAMP Cloud Special Interest Group Concept Papers
Monday, 25 Jul 2016 14.07